Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Minor revision history updates: added Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor UI/metadata tweaks include adding a 'Show glossary' option, introducing the label 'Last Update Submitted that Met QC Criteria', updating the revision to v3.4.0, and adjusting capitalization for several labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:24:11.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 on the page footer, reflecting a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-01-14T03:43:14.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a Locations section with Illinois; removed the Illinois Locations listing and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T20:54:21.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new revision tag v3.3.2 was added and an earlier revision tag v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:30:34.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The notice about government funding status was removed from the page, and this does not affect the trial details, eligibility criteria, or outcomes listed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.